Cargando…
Mortality reduction in 46 patients with severe COVID-19 treated with hyperimmune plasma. A proof-of-concept, single-arm, multicenter trial
Hyperimmune plasma from patients convalescing from COVID-19 is a potential treatment for severe COVID-19 in other patients. We conducted a multicenter, one-arm, proof-of-concept interventional study. Patients with COVID-19 with moderate-to-severe acute respiratory distress syndrome, elevated C-react...
Autores principales: | Perotti, Cesare, Baldanti, Fausto, Bruno, Raffaele, Del Fante, Claudia, Seminari, Elena, Casari, Salvatore, Percivalle, Elena, Glingani, Claudia, Musella, Valeria, Belliato, Mirko, Garuti, Martina, Meloni, Federica, Frigato, Marilena, Di Sabatino, Antonio, Klersy, Catherine, De Donno, Giuseppe, Franchini, Massimo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Fondazione Ferrata Storti
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7716363/ https://www.ncbi.nlm.nih.gov/pubmed/33256382 http://dx.doi.org/10.3324/haematol.2020.261784 |
Ejemplares similares
-
Plasma from donors recovered from the new Coronavirus 2019 as therapy for critical patients with COVID-19 (COVID-19 plasma study): a multicentre study protocol
por: Perotti, Cesare, et al.
Publicado: (2020) -
Impact of pathogen reduction technology on neutralizing antibody titer in COVID-19 convalescent plasma
por: Franchini, Massimo, et al.
Publicado: (2022) -
Early and persistent viral clearance in COVID-19 patients treated with convalescent plasma
por: Franchini, Massimo, et al.
Publicado: (2021) -
Convalescent plasma for coronavirus disease 2019 in pregnancy: a case report and review
por: Grisolia, Gianpaolo, et al.
Publicado: (2020) -
SARS-CoV-2 variants inactivation of plasma units using a riboflavin and ultraviolet light-based photochemical treatment
por: Ferrari, Alessandro, et al.
Publicado: (2022)